Of all the cases of economic espionage charged by the DOJ's National Security Division since 2012, more than 80% of them implicated China.World Politicsread more
"Whilst there is a big dispute at the moment, I think there's also potential for resolution," UBS chairman Axel Weber says of the U.S.-China trade negotiations.World Economyread more
Cryptocurrency fans will hope the futures contracts, which are federally regulated, can provide some much-needed legitimacy to bitcoin.Cryptocurrencyread more
Despite mixed fan and critic reactions to the final season of "Game of Thrones," the eight-season epic took home the top prize in the drama category at the Emmy Awards on...Entertainmentread more
There are alternative financial centers and investors can turn to Singapore, Tokyo or Shanghai if Hong Kong doesn't "shape up," says the founder and chairman of Citic Capital.Asia Economyread more
The Kingdom and oil and gas industry have been slow to shore up defenses, raising red flags about the possibility of longer term fall-out in the region.Technologyread more
Tensions between South Korea and Japan may ultimately disrupt the high-end tech sectors, says Heenam Choi, CEO at South Korea's sovereign wealth fund.Traderead more
On Sunday, the 71st Primetime Emmy Awards honored the best comedies, dramas, limited and variety series from the last year.Entertainmentread more
U.S. President Donald Trump's national security advisor said on Sunday that White House Asia policy adviser Matt Pottinger would become his top deputy.Politicsread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
Datadog went public on Thursday and instantly hit a $10 billion valuation, becoming the fourth cloud software debut to reach that level this year.Technologyread more
A Utah-based hospital chain pledged Wednesday to slash the number of opioid pills prescribed for patients with acute pain at its facilities by 40 percent by the end of 2018.
Intermountain Healthcare's pledge comes in the face of a worsening epidemic of painkiller and heroin abuse in the United States. In 2015, there were more than 33,000 fatalities from opioid overdoses recorded — almost half of which involved prescription painkillers.
If nonprofit Intermountain achieves its goal, it will reduce the number of opioid tablets it prescribes to patients with acute pain in Utah and southern Idaho by more than 5 million each year at its 22 hospitals and 180 clinics.
Intermountain said it believed it is the first American health system "to formally announce such a significant and specific amount of reduction as a target."
Dr. Marc Harrison, president and CEO of Intermountain, said, "We really want to make sure that we reduce the potential for abuse ... but still ensure that our patients have high-quality care."
Dr. Doug Smith, Intermountain's associate medical director, noted that nationslly there is a problem with health providers tending "to write prescriptions for more opioids than patients need, and large quantities of medications are often left over after the need for pain relief is past."
That opens the door for patients abusing their own medication, or the pills being abused by relatives or friends of a patient.
To reach its reduction goal, Intermountain will be using a "data-driven approach" spearheaded by a "business intelligence tool" that the health-care system developed to track prescriptions and develop guidelines for appropriate prescribing practices, Harrison said.
Intermountain also already has trained about 2,500 of its caregivers as part of the opioid reduction initiative.
Sales of prescription opioids have quadrupled since 1999, despite the fact that "there has not been an overall change in the amount of pain Americans report," according to the federal Centers for Disease Control and Prevention.
Utah, where most of Intermountain's facilities are located, has been particularly hard hit by the opioid crisis, with the state being ranked anywhere from seventh to 12th in the nation for overdoses, Harrison noted.
Intermountain, which has 850,000 members in the health insurance plan it operates, each year has some kind of interaction with 1.2 million people in Utah, which has a population of just 3 million.
"This is a big goal," Harrison said of the 40 percent reduction target.
"But our communities and the people in them are suffering, and we need to do something about that."
Harrison said that the prescription practices at Intermountain, which prescribes about 12.5 million opioid pills to patients with acute pain annually, have been "no better, no worse" than other health-care systems.
But "we can see that there's enormous variation" in the amount of painkillers being prescribed by different doctors across Intermountain's system, Harrison said.
"What you're seeing is what happens when there are not a lot of guidelines" about what an appropriate amount of pills are to be prescribed for various health situations, Harrison said.
Given this variation and analysis of prescribing patterns by Intermountain's staff, "they actually think that 40 percent [reduction] is a really good place to start ... there actually may be more room to move," Harrison said.
The experience of Kaiser Permanente, a major health-care system based in California, suggests that Harrison may be correct.
In 2009, Kaiser Permanente's Southern California division began an effort to reduce the number of patients who were getting high doses of opioids.
That move was launched after a group of doctors in the system noticed that the opioid hydrocodone was the most prescribed medication in Kaiser Permanente's health management organization in Southern California, while another opioid, OxyContin, was also high on that list.
"The numbers were so striking that it led us to look into it," Steinberg told the news site.
Kaiser Permanente has since expanded its opioid prescription initiative to its operations nationally.
According to data from Kaiser's Dr. Sameer Awsare that was provided to CNBC, Kaiser Permanente's system nationally reduced opioid prescriptions by 40 percent from December 2014 to this past February.
Awsare also said that it has decreased prescription amounts of OxyContin by 75 percent. The health system noted that OxyContin has a high potential for diversion and abuse because brand-name opioids have a higher street value.